These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1236 related articles for article (PubMed ID: 33031948)

  • 1. Follow-up of adults with noncritical COVID-19 two months after symptom onset.
    Carvalho-Schneider C; Laurent E; Lemaignen A; Beaufils E; Bourbao-Tournois C; Laribi S; Flament T; Ferreira-Maldent N; Bruyère F; Stefic K; Gaudy-Graffin C; Grammatico-Guillon L; Bernard L
    Clin Microbiol Infect; 2021 Feb; 27(2):258-263. PubMed ID: 33031948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013665. PubMed ID: 33620086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection.
    Schäfer E; Scheer C; Saljé K; Fritz A; Kohlmann T; Hübner NO; Napp M; Fiedler-Lacombe L; Stahl D; Rauch B; Nauck M; Völker U; Felix S; Lucchese G; Flöel A; Engeli S; Hoffmann W; Hahnenkamp K; Tzvetkov MV
    Sci Rep; 2022 May; 12(1):7249. PubMed ID: 35508524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study.
    Sudre CH; Keshet A; Graham MS; Joshi AD; Shilo S; Rossman H; Murray B; Molteni E; Klaser K; Canas LD; Antonelli M; Nguyen LH; Drew DA; Modat M; Pujol JC; Ganesh S; Wolf J; Meir T; Chan AT; Steves CJ; Spector TD; Brownstein JS; Segal E; Ourselin S; Astley CM
    Lancet Digit Health; 2021 Sep; 3(9):e577-e586. PubMed ID: 34305035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long COVID Clusters of Symptoms Persist beyond Two Years after Infection: Insights from the CARDIO COVID 20-21 Registry.
    Arango-Ibanez JP; Córdoba-Melo BD; Gutiérrez Posso JM; Barbosa-Rengifo MM; Herrera CJ; Quintana Da Silva MA; Buitrago AF; Coronel Gilio ML; Pow-Chong-Long F; Gómez-Mesa JE
    Viruses; 2024 Jun; 16(7):. PubMed ID: 39066191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper airway involvement in pediatric COVID-19.
    Parisi GF; Brindisi G; Indolfi C; Diaferio L; Marchese G; Ghiglioni DG; Zicari AM; Miraglia Del Giudice M
    Pediatr Allergy Immunol; 2020 Nov; 31 Suppl 26(Suppl 26):85-88. PubMed ID: 33236430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and characteristics of persistent symptoms after non-severe COVID-19: a prospective cohort study.
    Armange L; Bénézit F; Picard L; Pronier C; Guillot S; Lentz PA; Carré F; Tattevin P; Revest M
    Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2421-2425. PubMed ID: 33893570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological and clinical characteristics of survivors of SARS-COV-2 infection: A descriptive study.
    Olavegogeascoechea PA; Gallardo Martinez A; Scapellato JL; Federico A
    Medwave; 2022 Oct; 22(9):e2581. PubMed ID: 36283026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection.
    Patel A; Charani E; Ariyanayagam D; Abdulaal A; Denny SJ; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Sep; 26(9):1236-1241. PubMed ID: 32502645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study.
    Sampaio Rocha-Filho PA; Albuquerque PM; Carvalho LCLS; Dandara Pereira Gama M; Magalhães JE
    J Headache Pain; 2022 Jan; 23(1):2. PubMed ID: 34979899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric manifestations of COVID-19 can be clustered in three distinct symptom categories.
    Mirfazeli FS; Sarabi-Jamab A; Jahanbakhshi A; Kordi A; Javadnia P; Shariat SV; Aloosh O; Almasi-Dooghaee M; Faiz SHR
    Sci Rep; 2020 Dec; 10(1):20957. PubMed ID: 33262404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anosmia or Ageusia Following COVID-19 Vaccination: A Systematic Review.
    Arabzadeh Bahri R; Esmaeilpur Abianeh F; Peisepar M; Hadi R; Basti FA; Maleki S; Radkhah H
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):164S-170S. PubMed ID: 38411125
    [No Abstract]   [Full Text] [Related]  

  • 13. New Onset of Smell and Taste Loss Are Common Findings Also in Patients With Symptomatic COVID-19 After Complete Vaccination.
    Vaira LA; De Vito A; Lechien JR; Chiesa-Estomba CM; Mayo-Yàñez M; Calvo-Henrìquez C; Saussez S; Madeddu G; Babudieri S; Boscolo-Rizzo P; Hopkins C; De Riu G
    Laryngoscope; 2022 Feb; 132(2):419-421. PubMed ID: 34812498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term persistence of olfactory and gustatory disorders in COVID-19 patients.
    Nguyen NN; Hoang VT; Lagier JC; Raoult D; Gautret P
    Clin Microbiol Infect; 2021 Jun; 27(6):931-932. PubMed ID: 33418020
    [No Abstract]   [Full Text] [Related]  

  • 15. High Prevalence of Headaches During Covid-19 Infection: A Retrospective Cohort Study.
    Poncet-Megemont L; Paris P; Tronchere A; Salazard JP; Pereira B; Dallel R; Aumeran C; Beytout J; Jacomet C; Laurichesse H; Lesens O; Mrozek N; Vidal M; Moisset X
    Headache; 2020 Nov; 60(10):2578-2582. PubMed ID: 32757419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and factors associated with symptom persistence: A prospective study of 429 mild COVID-19 outpatients.
    Faycal A; Ndoadoumgue AL; Sellem B; Blanc C; Dudoit Y; Schneider L; Tubiana R; Valantin MA; Seang S; Palich R; Bleibtreu A; Monsel G; Godefroy N; Itani O; Paccoud O; Pourcher V; Caumes E; Ktorza N; Chermak A; Abdi B; Assoumou L; Katlama C;
    Infect Dis Now; 2022 Mar; 52(2):75-81. PubMed ID: 34800742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
    Dixon BE; Wools-Kaloustian KK; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
    PLoS One; 2021; 16(3):e0241875. PubMed ID: 33760821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous manifestations associated with anosmia, ageusia and enteritis in SARS-CoV-2 infection - A possible pattern? Observational study and review of the literature.
    Birlutiu V; Feiereisz AI; Oprinca G; Dobritoiu S; Rotaru M; Birlutiu RM; Iancu GM
    Int J Infect Dis; 2021 Jun; 107():72-77. PubMed ID: 33887455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases.
    Vaira LA; Deiana G; Fois AG; Pirina P; Madeddu G; De Vito A; Babudieri S; Petrocelli M; Serra A; Bussu F; Ligas E; Salzano G; De Riu G
    Head Neck; 2020 Jun; 42(6):1252-1258. PubMed ID: 32342566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 profiles in general practice: a latent class analysis.
    Ferrat E; Mirat W; Boutin E; Maroto E; Brossier S; Hoonakker JD; Audureau E; Phan TT; Bastuji-Garin S
    BMJ Open; 2024 Jun; 14(6):e080393. PubMed ID: 38844390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.